A hierarchical activation threshold shapes RSV F antibody repertoires from toddler vulnerability to adult protection
Deng, J.; Li, Y.; Lei, S.; Xu, K.; Nie, J.; Zhai, H.; Wang, J.; Xu, L.; Jian, F.; Feng, R.; Lv, Z.; Yu, W.; Ma, M.; Zhang, Y.; Zhang, C.; Wang, L.; Zhang, Y.; Hu, Y.; Xu, X.; Huang, W. J.; Liu, E.; Cao, Y. R.; Wang, X.
Show abstract
Respiratory syncytial virus (RSV) causes severe infant morbidity, yet the mechanisms underlying their suboptimal immunity and the failure of prefusion F-stabilized adult vaccines in infants remain unclear. Here we integrate deep mutational scanning of 761 preF-binding antibodies, repertoire profiling of 102 repeatedly exposed pediatricians and 61 RSV-experienced toddlers, structural analysis, and >40,000 viral genomes to decode RSV F immunity. We resolved 12 immunologically distinct functional antibody subclasses and uncovered a hierarchical activation threshold: apical epitope-targeting antibodies with superior neutralizing potency demand extensive somatic hypermutation and cooperative CDR networks, whereas central-to-basal epitope-directed, marginal or non-neutralizing antibodies engage germline-encoded antibodies through minimal mutations (e.g., S31G). Toddler repertoires are confined to low-threshold, non-productive sites; adult repertoires enrich for apical elite neutralizers whose immune pressure drives contemporary RSV-B evolution. These reframe pediatric RSV vulnerability as a threshold-gated repertoire deficit and prescribe vaccine strategies that actively redirect immunodominance from permissive epitopes toward high-barrier apical targets.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Optimizing a Human Monoclonal Antibody for Better Neutralization of SARS-CoV-2 98%
- Structural basis of broad protection against influenza virus by a human antibody targeting the neuraminidase active site via a recurring motif in CDR H3 98%
- Broadly neutralizing SARS-CoV-2 antibodies through epitope-based selection from convalescent patients 98%
Similar papers in this journal
Similar papers in this journal
- Crimean-Congo Hemorrhagic Fever Survivors Elicit Protective Non-Neutralizing Antibodies that Target 11 Overlapping Regions on Viral Glycoprotein GP38 98%
- Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individuals 98%
- Transient glycan-shield reduction induces CD4-binding site broadly neutralizing antibodies in SHIV-infected macaques 98%
Similar papers in this journal
- Analysis of the Diverse Antigenic Landscape of the Malaria Invasion Protein RH5 Identifies a Potent Vaccine-Induced Human Public Antibody Clonotype 97%
- Molecular basis for shifted receptor recognition by an encephalitic arbovirus 97%
- A SARS-CoV-2 neutralizing antibody protects from lung pathology in a COVID-19 hamster model 97%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.